SEARCH

SEARCH BY CITATION

References

  • 1
    Sapino, S., M. E. Carlotti, G. Caron, E. Ugazio and R. Cavalli (2009) In silico design, photostability and biological properties of the complex resveratrol/hydroxypropyl-b-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 63, 171180.
  • 2
    Stivala, L. A., M. Savio, F. Carafoli, P. Perucca, L. Bianchi, G. Maga, L. Forti, U. M. Pagnoni, A. Albinii, E. Prosperi and V. Vannini (2001) Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J. Biol. Chem. 276, 2258622594.
  • 3
    Athar, M., J. H. Back, X. Tang, K. Ho Kim, L. Kopelovich, D. R. Bickers and A. L. Kim (2007) Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol. Appl. Pharm. 224, 274283.
  • 4
    Aziz, M. H., F. Afaq and N. Ahmad (2005) Prevention of ultraviolet-B radiation damage by resveratrol in mouse skin is mediated via modulation in survivin. Photochem. Photobiol. 81, 2531.
  • 5
    Afaq, F., V. M. Adhami and N. Ahmad (2003) Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicol. Appl. Pharmacol. 186, 2837.
  • 6
    Kalra, N., P. Roy, S. Prasad and Y. Shukla (2008) Resveratrol induces apoptosis involving mitochondrial pathways in mouse skin tumorigenesis. Life Sci. 82, 348358.
  • 7
    Niles, R. M., M. McFarland, M. B. Weimer, A. Redkar, Y.-M. Fu and G. Meadows (2003) Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Lett. 190, 157163.
  • 8
    Weiss-Angeli, V., F. S. Poletto, L. R. Zancan and F. Baldasso (2008) Nanocapsules of octyl methoxycinnamate containing quercetin delayed the photodegradation of both components under ultraviolet A radiation. J. Biomed. Nanotechnol. 4, 8089.
  • 9
    Fontana, M. C., K. Coradini, A. R. Pohlmann, S. S. Guterres and R. C. R. Beck (2010) Nanocapsules prepared from amorphous polyesters: effect on the physicochemical characteristics, drug release, and photostability. J. Nanosci. Nanotechnol. 10, 30913099.
  • 10
    Ourique, A. F., A. R. Pohlmann, S. S. Guterres and R. C. R. Beck (2008) Rapid communication Tretinoin-loaded nanocapsules: preparation, physicochemical characterization, and photostability study. Int. J. Pharm. 352, 14.
  • 11
    Ioele, G., E. Cione, A. Risoli, G. Genchi and G. Ragno (2005) Accelerated photostability study of tretinoin and isotretinoinin liposome formulations. Int. J. Pharm. 293, 251260.
  • 12
    Schaffazick, S. R., S. S. Guterres, L. L. Freitas and A. R. Pohlmann (2003) Physicochemical characterization and stability of the polymeric nanoparticle system for drug administration. Quim. Nova, 26, 726737. (Portuguese)
  • 13
    Mora-Huertas, C. E., H. Fessi and A. Elaissari (2010) Polymer-based nanocapsules for drug delivery. Int. J. Pharm. 385, 113142.
  • 14
    Muller, R. H., K. Mader and S. Gohla (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur. J. Pharma. Biopharm. 50, 161177.
  • 15
    Ourique, A. F., S. Azoubel, C. V. Ferreira, C. B. Silva, M. C. L. Marchiori, A. R. Pohlmann, S. S. Guterres and R. C. R Beck (2010) Lipid-core nanocapsules as a nanomedicine for parenteral administration of tretinoin: development and in vitro antitumor activity on human myeloid leukaemia cells. J. Biomed. Nanotechnol. 6, 110.
  • 16
    Paese, K., A. Jäger, F. S. Poletto, E. Fonseca Pinto, B. Rossi-Bergmann, A. R. Pohlmann and S. S. Guterres (2009) Semisolid formulation containing a nanoencapsulated sunscreen: effectiveness, in vitro photostability and immune response. J. Biomed. Nanotechnol. 5, 17.
  • 17
    Frozza, R., A. L. Bernardi, K. Paese, J. B. Hoppe, T. da Silva, A. M. O. Battastini, A. R. Pohlmann, S. S. Guterres and C. Salbego (2010) Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats. J. Biomed. Nanotechnol. 6, 694703.
  • 18
    Ragno, G., E. Cione, A. Garofalo, G. Genchi, G. Ioele, A. Risoli and A. Spagnoletta (2003) Design and monitoring of photostability systems for amlodipine dosage forms. Int. J. Pharm. 265, 125132.
  • 19
    Mehnert, W. and K. Mäder (2001) Solid lipid nanoparticles production, characterization and applications. Adv. Drug Deliv. Rev. 47, 165196.
  • 20
    Shah, K. A., A. A. Date, M. D. Joshi and V. B. Patravale (2007) Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int. J. Pharm. 345, 163171.
  • 21
    Barnadas-Rodríguez, R. and M. Sabés (2001) Factors involved in the production of liposomes with a high-pressure homogenizer. Int. J. Pharm. 213, 175186.
  • 22
    Jager, A., V. Stefani, S. S. Guterres and A. R. Pohlmann (2007) Physico-chemical characterization of nanocapsule polymeric wall using fluorescent benzazole probes. Int. J. Pharm. 338, 297305.
  • 23
    Hung, C.-F., Y.-K. Lin, Z.-R. Huang and J.-Y. Fang (2008) Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin. Biol. Pharm. Bull. 31, 955962.
  • 24
    Guterres, S. S., M. P. Alves and A. R. Pohlmann (2007) Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights 2, 147157.
  • 25
    Puglia, C., F. Bonina, F. Castelli, D. Micieli and M. D. Sarpietro (2009) Evaluation of percutaneous absorption of the repellent diethyltoluamide and the sunscreen ethylhexyl p-methoxycinnamate-loaded solid lipid nanoparticles: an in vitro study. J. Pharm. Pharmacol. 61, 10131019.
  • 26
    Duncan, K. O., J. K. Geisse and D. J. Leffell (2008) Epithelial precancerous lesions. In Fitzpatrick’s Dermatology in General Medicine (Edited by K. Wolff, L. A. Goldsmith, S. I. Katz, B. A. Gilchrest, A. S. Paller and D. L. Leffell), pp. 10071027. McGraw-Hill Companies, New York, NY.
  • 27
    Kristl, J., K. Teskac, C. Caddeo, Z. Abramović and M. Šentjurc (2009) Improvements of cellular stress response on resveratrol in liposomes. Eur. J. Pharm. Biopharm. 73, 253259.
  • 28
    Teskac, K. and J. Kristl (2010) The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int. J. Pharm. 390, 6169.
  • 29
    Zattoni, A., E. L. Piccolomini, G. Torsi and P. Reschiglian (2003) Turbidimetric detection method in flow-assisted separation of dispersed samples. Anal. Chem. 75, 64696477.
  • 30
    Camont, L., C.-H. Cottart, Y. Rhayem, V. Nivet-Antoine, R. Djelidi, F. Collin, J.-L. Beaudeux and D. Bonnefont-Rousselot (2009) Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions. Anal. Chim. Acta 634, 121128.
  • 31
    Kang, K. C., C.-I. I. Lee, H.-B. Pyo and N.-H. Jeong (2005) Preparation and characterization of nano-liposomes using phosphatidylcholine. J. Ind. Eng. Chem. 11, 847851.
  • 32
    Pardeike, J., A. Hommoss and R. H. Müller (2009) Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int. J. Pharm. 366, 170184.
  • 33
    Mendonça, L. S., F. Firmino, J. N. Moreira, M. C. P. de Lima and S. Simões (2010) Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment. Bioconjug. Chem. 21, 157168.
  • 34
    New, R. R. C. (1990) Characterization of liposomes. In Liposomes: A Practical Approach (Edited by R. R. C. New), pp. 113117. Oxford University Press, New York, NY.
  • 35
    Alvarez-Lorenzo, C., L. Bromberg and A. Concheiro (2009) Light-sensitive intelligent drug delivery systems. Photochem. Photobiol. 85, 848860.
  • 36
    Heurtault, B., P. Saulnier, B. Pech, J.-E. Proust and J.-P. Benoit (2003) Physico-chemical stability of colloidal lipid particles. Biomaterials 24, 42834300.
  • 37
    Hung, C.-F., C.-L. Fang, M.-H. Liao and J.-Y. Fang (2007) Pharmaceutical Nanotechnology the effect of oil components on the physicochemical properties and drug delivery of emulsions: Tocol emulsion versus lipid emulsion. Int. J. Pharm. 335, 193202.
  • 38
    Rougeire, A., D. Dupuis, C. Lotte, R. Roguet and H. Schaefer (1983) In vivo correlation between stratum corneum reservoir function and percutaneous absorption. J. Invest. Dermatol. 81, 275278.
  • 39
    UNEP/ICNIRP/WHO (1994) Environmental Health Criteria 160, Health and Environmental Effects of Ultraviolet Radiation. WHO, Geneva.